{
  "docId": "019de073-bb7b-734e-9815-c76c1fc3394d",
  "docSlug": "94fe5c987d3cc2789a772bd63dd63a40",
  "documentTitle": "Genprex | Investor Presentation Deck | 39 slides",
  "authorId": "genprex",
  "authorName": "Genprex",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 39,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "traction",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The table displays patient-level outcomes including response type, prior therapy history, and number of prior lines of therapy.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-bb7b-734e-9815-c76c1fc3394d/14",
  "deckHref": "/decks/019de073-bb7b-734e-9815-c76c1fc3394d",
  "deckJsonHref": "/decks/019de073-bb7b-734e-9815-c76c1fc3394d.json",
  "deckAnchorHref": "/decks/019de073-bb7b-734e-9815-c76c1fc3394d#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.85
      },
      "kind": "paragraph",
      "text": "Combination therapy (re)sensitizes lung cancer cells and/or overcomes resistance to targeted therapies and other classes of drugs (i.e. anti-PD1 inhibitor). Slowed tumor progression in 7 out of 9 evaluable patients - 78% disease control rate (DCR; RECIST criteria). 9 out of 10 patients evaluable, all but one received prior treatments. One subject withdrew consent. Genprex does not intend to reopen enrollment in this Phase 1/2 trial.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e3a96ac-4655-40d3-8658-58d7d9b6984b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "table",
      "text": "Table showing patient EGFR status, response, prior therapy, and prior lines of therapy.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3e5c000-b852-44f8-b8e7-417b29c0a022",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.2,
        "y": 0.05
      },
      "kind": "title",
      "text": "REQORSA + TARCEVA COMBINATION",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c38c606a-b77e-4248-b568-84810be72379",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.2,
        "y": 0.11
      },
      "kind": "title",
      "text": "PHASE 2 DATA IN SUBJECTS WITH OR WITHOUT EGFR MUTATIONS",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e1d03d80-b1cb-469f-a52d-7d8c1fd157d4",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 13,
      "beatId": "efbd2b1c-a70c-482c-b892-45fe876c5387",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "REQORSA MONOTHERAPY, REQORSA + TARCEVA COMBINATION, etc.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}